Making New Drugs With a Dose of Artificial Intelligence

Researchers at DeepMind, owned by Google’s parent company, and other companies are applying their powerful A.I. systems to drug discovery research

Illustration: T.M. Detwiler

By Cade Metz

You can think of it as a World Cup of biochemical research.

This story is just a click away.

Sign up for a free Medium account to read this story from The New York Times. Plus, get one more story in your member preview this month.

Already have an account? Sign in

This story is just a click away.

Sign up for a free Medium account to read this story from The New York Times. Plus, get one more story in your member preview this month.
Already have an account? Sign in